Table 4.
N (%) | |
---|---|
Parameters after FAc Δ IOP < 6 mmHg (low responder) Δ IOP 6–15 mmHg (intermediate responder) Δ IOP > 15 mmHg (high responder) |
43 (69.4%) 17 (27.4%) 2 (3.2%) |
IOP > 21 mmHg IOP > 25 mmHg IOP > 30 mmHg IOP > 25 mmHg and/or gain > 10 mmHg (OHT) IOP > 30 mmHg and/or gain > 15 mmHg |
6 (9.7%) 4 (6.5%) 1 (1.6%) 7 (11.3%) 2 (3.2%) |
IOP procedures after FAc: All Introduction of monotherapy Introduction of dual therapy Switch monotherapy to dual therapy Switch dual therapy to quadruple therapy SLT only Total of SLT IOP-lowering surgery following topical therapy |
11 (17.7%) 2 (3.2%) 2 (3.2%) 4 (6.5%) 1 (1.6%) 2 (3.2%) 4 (6.5%) 1 (1.6%) |
BCVA: best corrected visual acuity; CMT: central macular thickness; DM: diabetes mellitus; DME: diabetic macular edema; DRIL: disorganization of retinal inner layers; ETDRS: early treatment diabetic retinopathy study; EZ/IZ: ellipsoid/interdigitation zone; HRF: hyperreflective foci; IRF: intraretinal fluid; PRP: panretinal photocoagulation SD: standard deviation; SRF: subretinal fluid.